Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus steroid for inflammatory response during congenital heart disease cardiac surgery in pediatric patients
PACTR202406581259613Not yet recruiting
- Sponsor
- Mansoura University Faculty of Medicine
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of dexmedetomidine in Cardiovascular Malformation (CVM) (2 arms), sponsored by Mansoura University Faculty of Medicine. Primary endpoints: Serum interleukin-6 level and Serum interleukin-8 level. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on PACTR202406581259613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202406581259613.